...
首页> 外文期刊>Letters in organic chemistry >Design, Synthesis and Biological Evaluation of 3-(3,4,5-Trimethoxyphenyl)-5-(2-(5-arylbenzo[b]thiophen-3-yl)oxazol-5-yl)isoxazole Derivatives as Anticancer Agents
【24h】

Design, Synthesis and Biological Evaluation of 3-(3,4,5-Trimethoxyphenyl)-5-(2-(5-arylbenzo[b]thiophen-3-yl)oxazol-5-yl)isoxazole Derivatives as Anticancer Agents

机译:3-(3,4,5-三甲氧基苯基)-5-(2-(5-芳基苯基[B]噻吩-3-基)恶唑-5-Y1)异恶唑衍生物的设计,合成和生物学评价为抗癌剂

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of 3-(3,4,5-trimethoxyphenyl)-5-(2-(5-arylbenzo[b]thiophen-3-yBoxa zol-5-yl)isoxazole derivatives were designed and synthesized. All these derivatives were evaluated for their anticancer activity against various human cancer cell lines such as MCF-7 (breast cancer), A549 (lung cancer), DU-145 (prostate cancer) and MDA MB-231 (breast cancer)-four human cancer cell lines by using MTT assay. Here, etoposide was used as a standard reference drug and most of the compounds were exhibited good anticancer activity with respect to cell lines. Among all compounds, five compounds 11b, 11c, 11f, 11i and 11j showed more potent activity than standard drug, in which, compound 11f was the most promising compound.
机译:设计并合成了一种新的3-(3,4,5-三甲氧基苯基)-5-(2-(5-芳基苯[B]噻吩-3- yboL-5-基)异恶唑衍生物。所有这些衍生物都是 评估它们对各种人类癌细胞系的抗癌活动,如MCF-7(乳腺癌),A549(肺癌),DU-145(前列腺癌)和MDA MB-231(乳腺癌) - 患者癌细胞系 使用MTT测定。这里,依托普苷作为标准参考药物,并且大多数化合物相对于细胞系表现出良好的抗癌活性。在所有化合物中,五种化合物11b,11c,11f,11i和11j表现出比 标准药物,其中,化合物11f是最有希望的化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号